Comparison of two alternative study designs in assessment of medicines utilisation in neonates

BMC Medical Research Methodology

Volumn 14, Issue 1, 2014, Pages

  Nellis, Georgi ^a,b   Lutsar, Irja ^a   Varendi, Heili ^b   Toompere, Karolin ^a   Turner, Mark A ^c,d   Duncan, Jennifer ^e   Metsvaht, Tuuli ^b  

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d LIVERPOOL WOMEN'S NHS FOUNDATION TRUST   (United Kingdom)

^e ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cross sectional studies; Data collection; Drug excipient exposure; Pharmacoepidemiologic methods

Indexed keywords

DRUG;

COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; HUMAN; INFORMATION PROCESSING; MEDICAL RESEARCH; METHODOLOGY; NEWBORN; PHARMACOEPIDEMIOLOGY; STATISTICAL MODEL;

BIOMEDICAL RESEARCH; CROSS-SECTIONAL STUDIES; DATA COLLECTION; HUMANS; INFANT, NEWBORN; LOGISTIC MODELS; PHARMACEUTICAL PREPARATIONS; PHARMACOEPIDEMIOLOGY; RESEARCH DESIGN;

EID: 84904273548     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-14-89     Document Type: Article

References (41)

1. DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic. Roberts JA, De Waele JJ, Dimopoulos G, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J, BMC Infect Dis 2012 12 152
2. Antifungal therapy in European hospitals: data from the ESAC point-prevalence surveys 2008 and 2009. Zarb P, Amadeo B, Muller A, Drapier N, Vankerckhoven V, Davey P, Goossens H, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 2012 18 389 E395
3. Point-prevalence study of inappropriate antibiotic use at a tertiary Australian hospital. Ingram PR, Seet JM, Budgeon CA, Murray R, Intern Med J 2012 42 719 721
4. European Surveillance of Antibiotic Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial prescribing in 32 hospitals of 21 European countries. Amadeo B, Zarb P, Muller A, Drapier N, Vankerckhoven V, Rogues A-M, Davey P, Goossens H, J Antimicrob Chemother 2010 65 2247 2252
5. The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Ansari F, Erntell M, Goossens H, Davey P, Clin Infect Dis an Off Publ Infect Dis Soc Am 2009 49 1496 1504
6. Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009. Zarb P, Amadeo B, Muller A, Drapier N, Vankerckhoven V, Davey P, Goossens H, J Antimicrob Chemother 2011 66 443 449
7. Methods in pharmacoepidemiology: a review of statistical analyses and data reporting in pediatric drug utilization studies. Sequi M, Campi R, Clavenna A, Bonati M, Eur J Clin Pharmacol 2013 69 599 604
8. European Surveillance of Antimicrobial Consumption (ESAC). Zarb P, Goossens H, Drugs 2011 71 745 755
9. Drug utilisation pattern and off-label use of medicines in Estonian neonatal units. Lass J, Käär R, Jõgi K, Varendi H, Metsvaht T, Lutsar I, Eur J Clin Pharmacol 2011 67 1263 1271
10. Epidemiological methods in diarrhoea studies-an update. Schmidt W-P, Arnold BF, Boisson S, Genser B, Luby SP, Barreto ML, Clasen T, Cairncross S, Int J Epidemiol 2011 40 1678 1692
11. European Study of Neonatal Exposure to Excipients (ESNEE). Turner M, Infant 2011 7 1 4
12. NEOMERO-European multicenter network to evaluate pharmacokinetics, safety and efficacy of Meropenem in neonatal sepsis and meningitis. http://www.neomero.org/
13. TINN European Survey on the Use of Antibiotics in NICUs. http://www.tinn-project.org/
14. A population-based observational study of restrictive guidelines for antibiotic therapy in early-onset neonatal infections. Labenne M, Michaut F, Gouyon B, Ferdynus C, Gouyon J-B, Pediatr Infect Dis J 2007 26 593 599 (Pubitemid 47014159)
15. Neonatal morbidity in late preterm and term infants in the nursery of a tertiary hospital. Dani C, Corsini I, Piergentili L, Bertini G, Pratesi S, Rubaltelli FF, Acta Paediatr (Oslo, Norw 1992) 2009 98 1841 1843
16. Admission of term infants to neonatal intensive care: a population-based study. Tracy SK, Tracy MB, Sullivan E, Birth 2007 34 301 307 (Pubitemid 350132642)
17. Perinatal characteristics and parents' perspective of health status of NICU graduates born at term. Schiariti V, Klassen AF, Houbé JS, Synnes A, Lisonkova S, Lee SK, J Perinatol Off J Calif Perinat Assoc 2008 28 368 376 (Pubitemid 351622263)
18. Heel blood sampling in European neonatal intensive care units: compliance with pain management guidelines. Losacco V, Cuttini M, Greisen G, Haumont D, Pallás-Alonso CR, Pierrat V, Warren I, Smit BJ, Westrup B, Sizun J, Arch Dis Child Fetal Neonatal Ed 2011 96 65 F68
19. Regionalization of perinatal care in Europe. Zeitlin J, Papiernik E, Bréart G, Semin Neonatol SN 2004 9 99 110 (Pubitemid 38364814)
20. Parents, siblings and grandparents in the Neonatal Intensive Care Unit. A survey of policies in eight European countries. Greisen G, Mirante N, Haumont D, Pierrat V, Pallás-Alonso CR, Warren I, Smit BJ, Westrup B, Sizun J, Maraschini A, Cuttini M, Acta Paediatr (Oslo, Norw 1992) 2009 98 1744 1750
21. Parental visiting, communication, and participation in ethical decisions: a comparison of neonatal unit policies in Europe. Cuttini M, Rebagliato M, Bortoli P, Hansen G, de Leeuw R, Lenoir S, Persson J, Reid M, Schroell M, de Vonderweid U, Kaminski M, Lenard H, Orzalesi M, Saracci R, Arch Dis Child Fetal Neonatal Ed 1999 81 84 F91
22. NUTS-Nomenclature of territorial units for statistics. [ http://epp.eurostat.ec.europa.eu/portal/page/portal/nuts-nomenclature/ introduction ]
23. Levels of neonatal care. Stark AR, Pediatrics 2004 114 1341 1347 (Pubitemid 41647699)
24. Modi N, British association of perinatal medicine London, UK Categories of Care 2011. 2011
25. Manufacturer's and wholesale dealer's licences. http://www.mhra.gov.uk/ Howweregulate/Medicines/Licensingofmedicines/ Manufacturersandwholesaledealerslicences/index.htm
26. A crossed random effects model for unbalanced data with applications in cross-sectional and longitudinal research. Raudenbush SW, J Educ Stat 1993 18 321 349
27. United Nations Statistics Division-composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings. http://unstats.un.org/unsd/methods/m49/m49regin.htm#europe
28. Extension of the modified Poisson regression model to prospective studies with correlated binary data. Zou GY, Donner A, Stat Methods Med Res 2013 22 661 670
29. Drug utilisation on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-based analysis. Neubert A, Lukas K, Leis T, Dormann H, Brune K, Rascher W, Eur J Clin Pharmacol 2010 66 87 95
30. Risk assessment of neonatal excipient exposure: Lessons from food safety and other areas. Turner MA, Duncan J, Shah U, Metsvaht T, Varendi H, Nellis G, Lutsar I, Yakkundi S, McElnay J, Pandya H, Mulla H, Vaconsin P, Storme T, Rieutord A, Nunn AJ, Adv Drug Deliv Rev 2014 73C 89 101
31. Study designs in paediatric pharmacoepidemiology. Verhamme K, Sturkenboom M, Eur J Clin Pharmacol 2011 67 Suppl 1 67 74
32. Capturing paediatric injury in Ontario: differences in injury incidence using self-reported survey and health service utilisation data. White HL, Macpherson AK, Inj Prev 2012 18 33 37
33. Incidence of diarrhea: poor parental recall ability. Melo MCND, Taddei JAD AC, Diniz-Santos DR, May DS, Carneiro NB, Silva LR, Brazilian J Infect Dis an Off Publ Brazilian Soc Infect Dis 2007 11 571 579
34. Reporting errors in one-week diarrhoea recall surveys: experience from a prospective study in rural Bangladesh. Alam N, Henry FJ, Rahaman M, Int J Epidemiol 1989 18 697 700 (Pubitemid 19268619)
35. Ongoing progress in research on drug exposure and adverse events. Knottnerus JA, Tugwell P, J Clin Epidemiol 2012 65 1029 1030
36. Gagnon JP, Rindress D, Pharmacoeconomics: Identifying The Issues USA: International Society for Pharmacoeconomics and Outcomes Research 1998
37. Benzyl alcohol metabolism and elimination in neonates. LeBel M, Ferron L, Masson M, Pichette J, Carrier C, Dev Pharmacol Ther 1988 11 347 356 (Pubitemid 19032151)
38. Benzyl alcohol toxicity: impact on mortality and intraventricular hemorrhage among very low birth weight infants the online version of this article, along with updated information and services, is located on the world wide web at: benzyl alcohol toxic. Hiller JL, Benda GI, Rahatzad M, Allen JR, David H, Carlson CV, Reynolds JW, Culver DH, Carison CV, Pediatrics 1986 77 500 506
39. Patterns of drug utilization in a neonatal intensive care unit. Warrier I, Du W, Natarajan G, Salari V, Aranda J, J Clin Pharmacol 2006 46 449 455
40. Reported medication use in the neonatal intensive care unit: data from a large national data set. Clark RH, Bloom BT, Spitzer AR, Gerstmann DR, Pediatrics 2006 117 1979 1987 (Pubitemid 46071242)
41. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Zarb P, Coignard B, Griskeviciene J, Muller A, Vankerckhoven V, Weist K, Goossens M, Vaerenberg S, Hopkins S, Catry B, Monnet D, Goossens H, Suetens C, Euro Surveill Bull Eur sur les Mal Transm = Eur Commun Dis Bull 2012 17 46 pii=20316